Skip to main content

Table 2 Mean MPR and persistence

From: Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

  Control Letter Phone Total
N = 51 N = 51 N = 53 N = 155
  Mean SD Mean SD Mean SD Mean SD
MPR (%) 70.4 31.8 79.7 27.9 78.4 26.5 76.2 28.9
Persistence (weeks) 38.6 17.5 44.7 16.8 42.8 14.8 42.1 16.5